Appellant contends that her doctor violated Georgia’s informed consent law by failing to advise her that ethylene diamine tetra acetic acide chelation (EDTA) therapy was available as an alternative to surgery. The district court granted summary judgment in favor of defendants/appellees on the ground that EDTA therapy is not a “generally recognized or accepted” alternative treatment for coronary surgery. We AFFIRM.
FACTUAL AND PROCEDURAL BACKGROUND
Appellant, Judith Moore, was suffering from a partial blockage of her left common carotid artery, which impeded the flow of oxygen to her brain and caused her to feel dizzy and tired. In April of 1989, she consulted with appellee Dr. Roy Baker, an employee of the Neurological Institute of Savannah, P.C. (NIS), about her symptoms. Dr. Baker diagnosed a blockage of her left carotid artery due to artherosclerotic plaque and recommended that she undergo a neurosurgical procedure known as a carotid endarterectomy to correct her medical problem.
Dr. Baker discussed the proposed procedure with Moore and advised her of the risks of undergoing the surgery. He did not advise her, however, of an alternative treatment known as EDTA therapy. Moore signed a written consent allowing *1131 Dr. Baker to perform the carotid endarter-ectomy on April 7, 1989. Following surgery, she appeared to recover well, but soon the hospital staff discovered that Moore was weak on one side. Dr. Baker reopened the operative wound and removed a blood clot that had formed in the artery. Although the clot was removed and the area repaired, Moore suffered permanent brain damage. As a result, Moore is permanently and severely disabled.
On April 8, 1991, the last day permitted by the statute of limitations, Moore filed a complaint alleging that Dr. Baker committed medical malpractice by failing to inform her of the availability of EDTA therapy as an alternative to surgery in violation of Georgia’s informed consent law, O.C.G.A. § 31-9-6.1 (1991). According to Moore’s complaint, EDTA therapy is as effective as carotid endarterectomy in treating coronary blockages, but it does not entail those risks that accompany invasive surgery.
On August 6, 1991 Dr. Baker filed a motion for summary judgment on the issue of informed consent. On August 26, 1991, Moore moved to amend her complaint to assert allegations of negligence by Dr. Baker in the performance of the surgery and in his post-operative care of Moore. Originally, on September 3, 1991, the district court granted Moore’s motion to amend her complaint. Shortly thereafter, the district court granted Dr. Baker’s motion for summary judgment on the informed consent issue, finding that EDTA therapy is not a “generally recognized or accepted” alternative treatment for coronary surgery. One month later, the district court vacated its September 3rd order and denied Moore’s motion to amend her complaint, thus terminating all of Moore’s outstanding claims. Moore now appeals the denial of her motion to amend her complaint as well as the grant of summary judgment in favor of Dr. Baker and NIS.
I.
Moore claims that the district court abused its discretion by vacating it’s earlier order and denying Moore’s motion to amend her complaint. Leave to amend a complaint “shall be freely given when justice so requires.” Fed.R.Civ.P. 15(a). While a decision whether to grant leave to amend is clearly within the discretion of the district court, a justifying reason must be apparent for denial of a motion to amend.
Nolin v. Douglas County,
Moore filed her original complaint on the last day permitted by Georgia’s statute of limitations.
See
O.C.G.A. § 9-3-71 (Supp.1992). Accordingly, the statute of limitations bars the claim asserted in Moore’s proposed amended complaint unless the amended complaint relates back to the date of the original complaint. An amendment relates back to the original filing “[wjhenever the claim or defense asserted in the amended pleading arose out of the conduct, transaction, or occurrence set forth or attempted to be set forth in the original pleading.” Fed.R.Civ.P. 15(c). The critical issue in Rule 15(c) determinations is whether the original complaint gave notice to the defendant of the claim now being asserted.
Woods Exploration & Producing Co., Inc. v. Aluminum Co. of America,
*1132
Moore relies heavily on
Azarbal v. Medical Center of Delaware, Inc.,
The instant case is clearly distinguishable from Azarbal. Unlike the complaint in Azarbal, the allegations asserted in Moore’s original complaint contain nothing to put Dr. Baker on notice that the new claims of negligence might be asserted. Even when given a liberal construction, there is nothing in Moore’s original complaint which makes reference to any acts of alleged negligence by Dr. Baker either during or after surgery. 1 The original complaint focuses on Baker’s actions before Moore decided to undergo surgery, but the amended complaint focuses on Baker’s actions during and after the surgery. The alleged acts of negligence occurred at different times and involved separate and distinct conduct. In order to recover on the negligence claim contained in her amended complaint, Moore would have to prove completely different facts than would otherwise have been required to recover on the informed consent claim in the original complaint.
We must conclude that Moore’s new claim does not arise out of the same conduct, transaction, or occurrence as the claims in the original complaint. Therefore, the amended complaint does not relate back to the original complaint, and the proposed new claims are barred by the applicable statute of limitations. Since the amended complaint could not withstand a motion to dismiss, we hold that the district court did not abuse its discretion in denying Moore’s motion to amend her complaint.
II.
Moore also challenges the district court’s grant of summary judgment on the issue of informed consent. Summary judgment is appropriate where the nonmovant fails to make a showing sufficient to establish the existence of an element essential to that party’s case.
Celotex Corp. v. Catrett,
The evidence overwhelmingly suggests that the mainstream medical community does not recognize or accept EDTA therapy as an alternative to a carotid endarterecto-my in treating coronary blockages. In his supporting affidavit, Dr. Baker avers that during his medical education, he never received any instruction relating to EDTA therapy as an alternative to a carotid en-darterectomy. A neurologist at the Medical College of Georgia confirmed that no one at the Medical College of Georgia teaches EDTA therapy or considers it a practical alternative to a carotid endarter-ectomy.' The record also reflects that a number of professional associations have voiced their opposition to EDTA therapy in this context. 2 Opposition to EDTA therapy is based not only upon the lack of objective evidence that the treatment is effective, but also upon evidence that the treatment may be dangerous.
Dr. Baker has produced ample evidence to negate an essential element of Moore’s claim, thus shifting the burden to Moore to make a showing sufficient to create a genuine issue of fact.
See Adickes v. S.H. Kress & Co.,
Moore has produced evidence that suggests that some physicians approve of EDTA chelation therapy. Dr. Baker, on the other hand, has produced overwhelming evidence tending to show that EDTA therapy is not generally recognized and accepted by reasonably prudent physicians as an alternative to surgery. Moore’s evidence is insufficient to create a genuine issue of material fact on the issue of whether EDTA chelation therapy is generally accepted. Therefore, we hold that the district court was correct in granting summary judgment in favor of Dr. Baker and NIS.
For all of the foregoing reasons, we AFFIRM the judgment of the district court.
Notes
. Moore’s original complaint is very specific and focuses solely on Dr. Baker's failure to inform Moore of EDTA therapy as an alternative to surgery. Although the complaint recounts the details of the operation and subsequent recovery, it does not hint that Dr. Baker's actions were negligent. In fact, the only references in the original complaint relating to the surgery or post-operative care suggest that Dr. Baker acted with reasonable care. The complaint states that "the nurses noticed a sudden onset of right sided weakness of which they immediately informed Defendant Baker." (Complaint, ¶ 18). “Upon being informed of this [right sided weakness], Defendant Baker immediately caused Plaintiff to be returned to the operation suite.... Although the clot was promptly removed by Defendant Baker...." (Complaint, ¶ 19).
. The American Medical Association published a document in 1983 that concluded EDTA therapy was not established as an acceptable treatment for coronary or other arterial atherosclerosis. The American Heart Association does not recommend EDTA therapy for treatment of heart disease because the benefits have not been scientifically proven. The American Academy of Family Physicians agreed that EDTA therapy is not an established treatment for atherosclerosis vascular disease. Both the American College of Cardiology and the American College of Physicians, have opposed the therapy except on an experimental basis.
. Q: Chelation therapy is not a conservative, standard or recognized treatment recognized by physicians who perform endarterectomies; is that a fair statement?
A: That’s true.
Q: Would that be true as well with cardiologists, neurosurgeons and physicians who perform vascular surgery, and cardiologists?
A: As of this point in time, since the FDA hasn’t approved its use for vascular disease, the great majority of physicians, including those you mentioned, would not advocate the use of chelation therapy for treatment of vascular disease. (Dr. Steenblock depo., pp. 120-21.)
. Dr. Susser, Aff., p. 6.
